Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Astria Therapeutics, Inc.Astria Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2024
Zoomcar Holdings, Inc.Zoomcar Holdings Reports 16% Revenue Decline, Net Loss Improvement in Q3 2024
OMEROS CORPOmeros Corporation Reports Net Loss, Decreased Cash Reserves, and Strategic Efforts in Q3 2024
WIDEPOINT CORPWidePoint Corporation Reports 35% Revenue Growth, Improved Financial Performance in Q3 2024
Ontrak, Inc.Ontrak Reports 31% Revenue Decline, Operating Loss in Q3 2024
M-tron Industries, Inc.M-tron Industries Reports 21.4% Revenue Growth and 43.7% Operating Income Increase in Q3 2024
Anterix Inc.Anterix Reports 47% Increase in Spectrum Revenue, Net Loss in Q2 2024
CHINA PHARMA HOLDINGS, INC.China Pharma Holdings Reports Significant Financial Challenges, Decline in Revenue and Gross Loss
Freenome, Inc.Perceptive Capital Solutions Reports Net Income of $981,482 in Q3 2024
ENTREPRENEUR UNIVERSE BRIGHT GROUPEntrepreneur Universe Bright Group Reports Decline in Revenue and Profitability for Q3 and Nine Months Ended September 30, 2024
GYRE THERAPEUTICS, INC.Gyre Therapeutics Reports Decline in Revenue and Operating Income in Q3 2024, Despite Strategic Progress
BTCS Inc.BTCS Inc. Reports 134% Revenue Growth, Net Loss in Q3 2024 Amid Challenging Market Conditions
AA Mission Acquisition Corp.Mission Acquisition Corp. Reports Financial Results for the Three Months Ending September 30, 2024
CalciMedica, Inc.CalciMedica Reports Financial Update, Advances Lead Product Candidate Auxora
IMMUCELL CORP /DE/ImmuCell Corporation Reports 11.4% Revenue Growth, Improved Gross Margins, and Reduced Net Loss in Q3 2024
BioCardia, Inc.BioCardia Reports Improved Liquidity, Reduced Losses, and Capital Raising Efforts in Latest 10-Q Filing
PARKERVISION INCParkerVision Reports Significant Financial Challenges, No Revenue for Nine Months Ending September 30, 2024
Strategic Realty Trust, Inc.Strategic Realty Trust Reports Significant Asset Decline, Net Assets in Liquidation Decrease
Aimei Health Technology Co., Ltd.Aimei Health Technology Reports Mixed Financial Results, Net Income Turnaround in Latest Quarter
AirJoule Technologies Corp.AirJoule Technologies Reports Significant Financial Growth Following Merger, Net Income Turnaround
PERMA FIX ENVIRONMENTAL SERVICES INCPerma-Fix Environmental Services Reports Significant Financial Challenges in Q3 and Nine-Month Results
Pony Group Inc.Pony Group Inc. Reports Significant Revenue and Profit Declines in Q3 and Nine Months Ended September 30, 2024
NOCOPI TECHNOLOGIES INC/MD/Nocopi Technologies Reports Mixed Q3 Results, 16% Revenue Growth, and Improved Gross Profit Margin
AN2 Therapeutics, Inc.AN2 Therapeutics Reports Improved Financials, Restructuring, and Clinical Trial Plans
ACTUATE THERAPEUTICS, INC.Actuate Therapeutics Reports Improved Financials, Net Loss, and Cash Reserves in Latest 10-Q Filing